Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SCNI

Scinai Immunotherapeutics Ltd.

Healthcare · USD

Set alert

Price alert · SCNI

All alert types
0.47 USD -0.05 -9.05%
As of Oct 30, 2026 Extended hours 0.49 +3.22%
Bid
0.44 × 1
Ask
0.48 × 1
0.47 Day range 0.545
0.4716 52-week range 14.60
YTD
-93.38%
1 year
-96.77%
Open
0.545
Prev close
0.5185
Mkt cap
1.24M
Vol
52.95K
Avg vol
2.15M
EPS
28.07
P/E
0.02
Div yield
0.00%
More statistics
Low
0.47
High
0.545
Forward P/E
0.00
Beta
2.46
Short ratio
0.09
Inst. own
2.36%
Dividend
0.00
Ex-div date
50-d avg
3.41
200-d avg
3.91
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SCNI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-11.55 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -0.2×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: 0.6×FY 2025: -0.2×
FY 2016 5y median -0.0× FY 2025
P/S 1.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 4.1×FY 2025: 1.3×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016: 1.7×FY 2017: 1.7×FY 2018: -3.7×FY 2019: -4.0×FY 2020: -0.0×FY 2021: 0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.0× FY 2025
P/FCF -0.3×
FY 2016: -4.5×FY 2017: -6.6×FY 2018: -1.4×FY 2019: -3.1×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.4×FY 2025: -0.3×
FY 2016 5y median -0.0× FY 2025
EV/EBITDA -0.3×
FY 2016: -2.5×FY 2017: -1.1×FY 2018: -1.8×FY 2019: -4.2×FY 2020: -0.9×FY 2021: -1.1×FY 2022: -1.4×FY 2023: -7.2×FY 2024: -0.4×FY 2025: -0.3×
FY 2016 5y median -1.1× FY 2025
EV/Sales 1.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 4.3×FY 2025: 1.7×
FY 2016 5y median 0.0× FY 2025
FCF Yield -364.2%
FY 2016: -22.2%FY 2017: -15.1%FY 2018: -69.4%FY 2019: -32.2%FY 2020: -293868.8%FY 2021: -91232.8%FY 2022: -58070.0%FY 2023: -172413.7%FY 2024: -235.0%FY 2025: -364.2%
FY 2016 5y median -58070.0% FY 2025

Profitability

Gross Margin -202.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -88.1%FY 2025: -202.3%
FY 2016 5y median 0.0% FY 2025
Operating Margin -575.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1312.8%FY 2025: -575.3%
FY 2016 5y median 0.0% FY 2025
Net Margin -633.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 728.9%FY 2025: -633.6%
FY 2016 5y median 0.0% FY 2025
ROE -102.5%
FY 2016: -35.9%FY 2017: -61.4%FY 2018: 281.0%FY 2019: 167.9%FY 2020: 28.5%FY 2021: -1260.3%FY 2022: 329.3%FY 2023: 142.3%FY 2024: 48.1%FY 2025: -102.5%
FY 2016 5y median 48.1% FY 2025
ROIC -72.7%
FY 2016: -41.4%FY 2017: -31.6%FY 2018: -91.7%FY 2019: -80.4%FY 2020: -118.4%FY 2021: -35.7%FY 2022: -44.0%FY 2023: -60.3%FY 2024: -71.6%FY 2025: -72.7%
FY 2016 5y median -60.3% FY 2025
ROA -71.5%
FY 2016: -30.5%FY 2017: -42.3%FY 2018: -82.9%FY 2019: -94.3%FY 2020: -7.3%FY 2021: -38.6%FY 2022: -21.4%FY 2023: -37.2%FY 2024: 35.7%FY 2025: -71.5%
FY 2016 5y median -37.2% FY 2025

Growth (YoY)

Revenue 99.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 99.2%
FY 2016 FY 2025
Operating Income 12.7%
FY 2016: -6.5%FY 2017: -120.1%FY 2018: -203.1%FY 2019: -10.1%FY 2020: 12.7%FY 2021: 45.5%FY 2022: -2.5%FY 2023: 12.3%FY 2024: 11.0%FY 2025: 12.7%
FY 2016 FY 2025
EPS (diluted) -160.0%
FY 2016: 28.9%FY 2017: -179.9%FY 2018: -81.7%FY 2019: -7.9%FY 2020: 97.0%FY 2021: -650.2%FY 2022: 95.4%FY 2023: 60.0%FY 2024: 100.1%FY 2025: -160.0%
FY 2016 FY 2025
Free Cash Flow 4.6%
FY 2016: 5.0%FY 2017: -66.6%FY 2018: -417.2%FY 2019: -13.1%FY 2020: 6.5%FY 2021: 66.9%FY 2022: -7.1%FY 2023: -23.7%FY 2024: 36.7%FY 2025: 4.6%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 19.0×FY 2017: 10.9×FY 2018: 3.5×FY 2019: 3.9×FY 2020: 0.2×FY 2021: 7.3×FY 2022: 6.1×FY 2023: 3.1×FY 2024: 1.3×FY 2025: 1.3×
FY 2016 5y median 3.1× FY 2025
Quick Ratio 1.3×
FY 2016: 19.0×FY 2017: 10.9×FY 2018: 3.5×FY 2019: 3.9×FY 2020: 0.2×FY 2021: 7.3×FY 2022: 6.1×FY 2023: 3.1×FY 2024: 1.3×FY 2025: 1.3×
FY 2016 5y median 3.1× FY 2025
Debt / Equity 0.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -3.0×FY 2019: -2.0×FY 2020: -4.6×FY 2021: 29.8×FY 2022: -12.2×FY 2023: -4.5×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: 1.4×FY 2017: 3.1×FY 2018: -0.2×FY 2019: -0.8×FY 2020: -0.9×FY 2021: -1.1×FY 2022: -1.4×FY 2023: -7.2×FY 2024: -0.0×FY 2025: -0.1×
FY 2016 5y median -1.1× FY 2025
Interest Coverage -21.0×
FY 2016: -30890×FY 2017: -332×FY 2018: -5.4×FY 2019: -5.3×FY 2020: -58.5×FY 2021: -3.2×FY 2022: 0.0×FY 2023: -2.6×FY 2024: -6.0×FY 2025: -21.0×
FY 2016 5y median -3.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31